|ITEM METADATA RECORD
|Title: ||Pexelizumab, a C5 complement inhibitor, reduces 30-day mortality in patients undergoing coronary artery bypass surgery or receiving reperfusion therapy for acute myocardial infarction|
|Authors: ||Van de Werf, Frans|
|Issue Date: ||2004 |
|Publisher: ||Elsevier Biomedical|
|Host Document: ||Journal of the American College of Cardiology vol:43 issue:5 pages:474A-474A|
|Conference: ||54th Annual Scientific Session of the American-College-of-Cardiology location:New Orleans date:07-10 March 2004|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Cardiology |
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.